FY2025 · period end Dec '25 · from the 10-K filed Feb 13, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $16.23B |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001043277-26-000023 | May 29, 2026 | Jun 2, 2026 | Jun 2, 2026 20:18 UTC | EDGAR |
| 8-K | 0001043277-26-000018 | May 7, 2026 | May 11, 2026 | May 11, 2026 20:05 UTC | EDGAR |
| 10-Q | 0001043277-26-000016 | Mar 31, 2026 | May 1, 2026 | May 1, 2026 15:49 UTC | EDGAR |
| 8-K | 0001043277-26-000014 | Apr 29, 2026 | Apr 29, 2026 | Apr 29, 2026 20:11 UTC | EDGAR |
| 10-K | 0001043277-26-000009 | Dec 31, 2025 | Feb 13, 2026 | Feb 13, 2026 19:23 UTC | EDGAR |
| 8-K | 0001043277-26-000005 | Jan 28, 2026 | Jan 28, 2026 | Jan 28, 2026 21:16 UTC | EDGAR |
| 10-Q | 0001043277-25-000052 | Sep 30, 2025 | Oct 31, 2025 | Oct 31, 2025 19:30 UTC | EDGAR |
| 8-K | 0001043277-25-000050 | Oct 29, 2025 | Oct 29, 2025 | Oct 29, 2025 20:26 UTC | EDGAR |
Direct links to SEC EDGAR. CHRW has additional filings available on the SEC site.
6 numbers C. H. ROBINSON WORLDWIDE, INC. later changed — same XBRL tag, both filings linked.
Revenues·Q2 2017
Major restatementwas$3.7B
Revised down in a 10-Q. Any P/S built on the original was 546.6% too low.
Revenues·Q3 2017
Major restatementwas$3.8B
Revised down in a 10-Q. Any P/S built on the original was 537.3% too low.
Long-term Debt·As of Dec 31, 2017
Major restatementwas$750M
Revised up in a 10-K.
Deferred Tax Assets, Operating Loss Carryforwards, Foreign·As of Dec 31, 2022
Major restatementwas$9M
Revised up in a 10-K.
Deferred Income Tax Expense (Benefit)·Q2 2012
Major restatementwas$6M
Revised down in a 10-Q.
Deferred Income Tax Expense (Benefit)·Q3 2012
Major restatementwas$6.3M
Revised down in a 10-Q.
CHRW is not the only one.
See every restatement we've found across the market — or get an alert the next time CHRW revises a number.
Restatements are detected by comparing every vintage of a fact across all of C. H. ROBINSON WORLDWIDE, INC.'s filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows CHRW's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling C. H. ROBINSON WORLDWIDE, INC. — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on CHRW yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on CHRW and publish the result to your public profile.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $17.60B |
| $24.70B |
| $23.10B |
| Gross Profit | — | — | — | — | — |
|---|
| Operating Income | $0.79B | $0.67B | $0.51B | $1.27B | $1.08B |
|---|
| Net Income | $0.59B | $0.47B | $0.33B | $0.94B | $0.84B |
|---|
| EPS (Diluted) | $4.83 | $3.86 | $2.72 | $7.40 | $6.31 |
|---|
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $5.06B | $5.30B | $5.23B | $5.95B | $7.03B |
| Total Liabilities | $3.21B | $3.58B | $3.81B | $4.60B | $5.01B |
| Stockholders' Equity | $1.85B | $1.72B | $1.42B | $1.35B | $2.02B |
| Cash & Equivalents | $0.16B | $0.15B | $0.15B | $0.22B | $0.26B |
| Total Debt | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $0.91B | $0.51B | $0.73B | $1.65B | $0.09B |
| Capital Expenditures | $0.02B | $0.02B | $0.03B | $0.06B | $0.03B |
| Free Cash Flow | $0.89B | $0.49B | $0.70B | $1.59B | $0.06B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | — |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.1% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Return on Equity | 32.9% | 29.7% | 23.5% | 55.7% | 43.3% |
| Return on Assets | 11.3% | 8.9% | 5.8% | 14.5% | 13.9% |
| Debt / Equity | 1.43× | 2.92× | 3.97× | 5.56× | 3.05× |
